← All Companies
BIOMARIN PHARMACEUTICAL INC
BMRN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $10.4B · 3,221 employees
Business Summary Part I Overview BioMarin Pharmaceutical Inc. (BioMarin, we, us or our) is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Our San Rafael, California-based company, founded in 1997, has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, we seek to unleash the full potential of g...
Latest Stock Quote
BMRN 2026-05-22
$54.09
O:$54.04 H:$55.05 L:$53.56 Vol:2.4M VWAP:$54.0878
origin leaf: 9b78c8ead131d96185ee7e4d013d13223918f224a87dd538fa176dd1be0fc78d
Next Earnings Q2 FY2026 — expected 2026-08-15
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention BMRN discussed Blockchain & Crypto topic_mention BMRN discussed Semiconductor topic_mention BMRN discussed Supply Chain topic_mention BMRN discussed Regulation topic_mention BMRN discussed Automotive topic_mention BMRN discussed Healthcare & Bio metric BMRN gross margin reported $12.7 percent metric BMRN EPS reported $1.80
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-02-26 2025-12-31 0001048477-26-000004 EDGAR 86K words 2025-02-24 2024-12-31 0001048477-25-000007 EDGAR — 2024-02-26 2023-12-31 0001048477-24-000016 EDGAR — 2023-02-27 2022-12-31 0001048477-23-000009 EDGAR — 2022-02-25 2021-12-31 0001048477-22-000012 EDGAR — 2021-02-26 2020-12-31 0001048477-21-000008 EDGAR — 2020-02-27 2019-12-31 0001048477-20-000009 EDGAR — 2019-02-28 2018-12-31 0001564590-19-005033 EDGAR — 2018-02-26 2017-12-31 0001564590-18-003114 EDGAR — 2017-02-27 2016-12-31 0001564590-17-002483 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-10-28 2025-09-30 0001048477-25-000107 EDGAR 45K words 2025-08-05 2025-06-30 0001048477-25-000090 EDGAR — 2025-05-02 2025-03-31 0001048477-25-000051 EDGAR — 2024-10-31 2024-09-30 0001048477-24-000152 EDGAR — 2024-08-05 2024-06-30 0001048477-24-000126 EDGAR — 2024-04-26 2024-03-31 0001048477-24-000070 EDGAR — 2023-11-02 2023-09-30 0001048477-23-000044 EDGAR — 2023-08-02 2023-06-30 0001048477-23-000029 EDGAR — 2023-04-28 2023-03-31 0001048477-23-000020 EDGAR — 2022-10-28 2022-09-30 0001048477-22-000033 EDGAR — 2022-08-04 2022-06-30 0001048477-22-000027 EDGAR — 2022-04-29 2022-03-31 0001048477-22-000018 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-16 0001193125-26-107314 EDGAR 1K words 2026-02-23 0001048477-26-000002 EDGAR — 2026-02-12 0001193125-26-048736 EDGAR — 2026-01-29 0001193125-26-029401 EDGAR — 2026-01-26 0001193125-26-021718 EDGAR — 2026-01-12 0001193125-26-010508 EDGAR — 2025-12-22 0001193125-25-327828 EDGAR — 2025-12-19 0001193125-25-325856 EDGAR — 2025-12-17 0001193125-25-322704 EDGAR — 2025-10-27 0001048477-25-000104 EDGAR —
155 total filings indexed. 123 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Earnings Transcripts Call Date Quarter Title — BMRN Earnings Call Transcript
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
Sector Peers Company Identity
CIK 0001048477
Ticker BMRN
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Website https://www.biomarin.com
Listed 1999-07-23
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 2a0331874e128b9516f12634be26e1ae61a79e37b4bce2184d79f3c2ec963790
parent: 30952e672fa99653e3f0ff1c6875c427860c7445105cd7f57dc8ec1b9773c9d6
content hash: 216a8d85ad21d16d2e5159230722455f111a965774ec16af11970ce3fcf9fef0
signed: 2026-06-02T19:00:27.684Z
sources: 24 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf